Medical Position Statements
go go go

Medical Position Statements

Medical Position Statements are developed under the aegis of the Clinical Practice and Quality Management Committee and provide preferred approaches to specific medical problems or issues.

The process by which our medical positions statements (also referred to as clinical practice guidelines) are developed is described in the Practice Recommendations Manual .

All downloads available on this site are in PDF format. To order a hard copy of any of these statements, please order online or contact AGA Member Services at member@gastro.org or (301) 941-2651 to request an order form.

Contact Sheila Agyeman to suggest a topic for this page.

View the archived medical position statments.

All Medical Position Statements and Technical Reviews released prior to 2003 were reviewed and reapproved by the Clinical Practice & Quality Committee on
September 19, 2008

= Medical Position Statement
= Technical Review
= FDA Medwatch Alert

Name
Available
Released
Acute Pancreatitis
MPS TR
05/07
Anal Fissure
MPS TR
01/03
Chronic Diarrhea
MPS TR
06/99
Celiac Disease
MPS TR
12/06
Celiac Sprue
MPS TR
05/01
Colonoscopy Surveillance After Cancer Resection
MPS FDA
09/06
Colorectal Cancer Screening and Surveillance
MPS FDA
02/03
Colorectal Cancer Screening and Surveillance for Early Detection
MPS FDA
03/08
Constipation
MPS TR FDA
12/00
CT Colonography
MPS FDA
07/06
CT Colonography Standards
MPS FDA
09/07
Dyspepsia
MPS TR
11/05
Endoscopic Sedation
MPS 
08/07
Endoscopic Therapy for GERD
MPS TR
10/06
Endoscopy, Technology Assessment
MPS
03/08
Esophageal Carcinoma
MPS TR
05/05
Esophageal Manometry
MPS TR
01/05
Gastric Subepithelial Masses
MPS TR
06/06
Gastroesophageal Reflux Disease (GERD) new
MPS TR FDA
10/08
Gastroparesis
MPS TR FDA
11/04
GI Medication in Pregnancy
MPS TR FDA
07/06
Hemorrhoids
MPS TR
05/04
Hepatitis C
MPS TR
01/06
Inflammatory Bowel Disease
MPS TR
03/06
Intestinal Ischemia
MPS TR FDA
05/00
Irritable Bowel Syndrome
MPS TR FDA
12/02
Liver Chemistry Tests
MPS TR
10/02
Nausea and Vomiting
MPS TR
01/01
Obscure Gastrointestinal Bleeding, (revised)
MPS MPS 
11/07
Oropharyngeal Dysphagia
MPS TR
02/99
Osteoporosis in Gastrointestinal Diseases
MPS TR
03/03
Osteoporosis in Hepatic Disorders
MPS TR
09/03
Perianal Crohn’s Disease
MPS TR
11/03
Sedation
MPS 
03/04
Short Bowel Syndrome and Intestinal Transplantation
MPS FDA
04/03
Stem Cell Research and It's Implications for Treating GI Cancers new
MPS
11/08


Gastroenterology and Clinical Gastroenterology and Hepatology (CGH) are members of the Medscape Publishers' Circle®, an alliance of leading medical publishers whose content is featured on Medscape. Medscape is part of the WebMD Medscape Health Network, a leading online healthcare resource for professionals and consumers. Selected Gastroenterology and Clinical Gastroenterology & Hepatology articles are available.

 

Medical Position Statements are derived from the data available at the time of their creation and may need to be modified as new information is generated.

Unless otherwise stated, these statements are intended for adult patients.

The strength of the evidence upon which the statements are based is noted, with prospective, randomized, controlled trials being the strongest. When adequate data are absent, expert consensus may be used and will be identified as such.

These documents are not to be construed as standards of care. All decisions regarding the care of a patient should be made by the physician in consideration of all aspects of the patient's specific medical circumstances.

A comprehensive background paper, the Technical Review, provides the user of the Medical Position Statement with the evidence used to formulate a particular recommendation and the strength and character of that evidence.

img